title: Principles of separation: indications and therapeutic targets for plasma exchange.
abstract: Extracorporeal "blood purification," mainly in the form of hemodialysis has been a major portion of the clinical activity of many nephrologists for the past 5 decades. A possibly older procedure, therapeutic plasma exchange, separates and then removes plasma as a method of removing pathogenic material from the patient. In contrast to hemodialysis, therapeutic plasma exchange preferentially removes biologic substances of high molecular weight such as autoantibodies or alloantibodies, antigen-antibody complexes, and Ig paraproteins. These molecular targets may be cleared through two alternative procedures: centrifugal separation and membrane separation. This review presents operational features of each procedure, with relevance to the nephrologist. Kinetics of removal of these plasma constituents are based on the principles of separation by the apheresis technique and by features specific to each molecular target, including their production and compartmentalization in the body. Molecular targets for common renal conditions requiring therapeutic plasma exchange are also discussed in detail.
authors.affiliation: Renal Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, †Division of Nephrology, University of Virginia, Charlottesville, Virginia.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Williams
authors.forename: Rasheed A
authors.initials: RA
authors.lastname: Balogun
mesh_terms: D000906:Antibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001781:Blood Component Removal; D002498:Centrifugation; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000276:immunology / Q000628:therapy*; D009398:Nephrology / Q000379:methods*; D010951:Plasma Exchange / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D015415:Biomarkers